Clinical Trials
3 trialsNCT00915083 2019-11-01
A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.
Celgene
Phase 1 Completed
NCT00890955 2015-12-23
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
Hoosier Cancer Research Network
Phase 1 Completed
NCT00132054 2013-05-30
Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed